Boehringer Ingelheim has landed an exclusive license to Prime Vector Technologies’ viral vector platform for developing next-generation cancer vaccines.
A new rock-breaking technique that harnesses the devastating power of underground rockbursts could revolutionize mining, tunneling, and construction by shattering…